Roger R. Blunt
Directeur/Membre du Conseil chez Fyodor Biotechnologies, Inc.
Profil
Roger R.
Blunt currently works at Fyodor Biotechnologies, Inc., as Non-Executive Director.
Postes actifs de Roger R. Blunt
| Sociétés | Poste | Début |
|---|---|---|
Fyodor Biotechnologies, Inc.
 Fyodor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Fyodor Biotechnologies, Inc.
Fyodor Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Fyodor Biotechnologies, Inc. is a healthcare company based in Baltimore, MD. Fyodor Biotechnologies has developed the Urine Malaria Test (UMT), which is the first and only non-blood test that tells in minutes if a fever is malaria, using a few drops of urine. The UMT is a disruptive innovation for malaria testing backed by top-rate science, and validated in a highly acclaimed pivotal clinical trial. The company's goal is to make it possible to test or be tested for malaria fast, at home or at a healthcare facility, and be promptly treated with over-the-counter antimalarial medicine. The company was founded by Eddy C. Agbo, who has been the CEO since incorporation. | Health Technology |
